FDA Inspection 1182325 — CSL Plasma Inc.
The FDA completed an inspection of CSL Plasma Inc. on Oct 19, 2022 in East Point, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 19, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- East Point, GA (United States)